TrialMuscle & nerve2021

Tocilizumab is safe and tolerable and reduces C-reactive protein concentrations in the plasma and cerebrospinal fluid of ALS patients.

Carol Milligan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.